News
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Weight-loss drugs are already dropping in price; could they go even lower? - Consumers are now able to pay roughly $500 for ...
A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...
The price of weight loss drugs is falling. Wegovy and Zepbound, which both sell for a list price of more than $1,000 a month, have long been out of reach for people without insurance or whose ...
The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...
The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...
A UK watchdog is urging women on GLP-1 weight-loss drugs like Ozempic and Mounjaro to use effective forms of birth control after receiving more than 40 pregnancy-related reports linked to the ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment ...
Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, ...
Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...
Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results